Evidence map›Paper›PMID 40501901›Full record

ArticlebioRxiv : the preprint server for biology2025

PLIERv2: bigger, better and faster.

Marc Subirana-Granés, Sutanu Nandi, Haoyu Zhang, Maria Chikina, Milton Pividori

Abstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Marc Subirana-GranésDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0000-0003-3934-839X
Sutanu NandiDepartment of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0009-0001-5887-999X
Haoyu ZhangDepartment of Biomedical Informatics, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.ORCID 0009-0005-6025-0217
Maria ChikinaDepartment of Computational and Systems Biology, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA.ORCID 0000-0003-2550-5403
Milton PividoriDepartment of Biomedical Informatics, University of Colorado School of Medicine, Aurora, CO 80045, USA.ORCID 0000-0002-3035-4403

Funding

Novel computational strategies to deconvolute co-occurring conditions in Down syndromeR01HD109765 · NICHD · UNIVERSITY OF COLORADO DENVER · PI James Christopher Costello, Casey S Greene · 2022 to 2026
$4.1M
Title: Functional Annotation of Genomes via Phenotypic Convergence within Large Multi-species AlignmentsR01HG009299 · NHGRI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Maria D Chikina, Nathaniel L Clark · 2017 to 2026
$4.1M
Discovery and characterization of ocular regulatory elements through evolutionary analysisR01EY030546 · NEI · UNIVERSITY OF UTAH · PI CHIKINA, MARIA D, CLARK, NATHANIEL L · 2020 to 2024
$2.4M
Computational approaches to characterize heterogeneity and improve risk stratification in complex disease phenotypesR00HG011898 · NHGRI · UNIVERSITY OF COLORADO DENVER · PI PIVIDORI, MILTON · 2023 to 2025
$747k
NEI NIH HHS R01 EY030546NHGRI NIH HHS R00 HG011898NHGRI NIH HHS R01 HG009299NICHD NIH HHS R01 HD109765
6 · The paper itself

Abstract

Gene expression analysis has long been fundamental for elucidating molecular pathways and gene-disease relationships, but traditional single-gene approaches cannot capture the coordinated regulatory networks underlying complex phenotypes; although unsupervised matrix factorization methods (e.g., PCA, NMF) reveal coexpression patterns, they lack the ability to incorporate prior biological knowledge and often struggle with interpretability and technical noise correction. Semi-supervised strategies such as PLIER have improved interpretability by integrating pathway annotations during latent variable extraction, yet the original PLIER implementation is prohibitively slow and memory-intensive, making it impractical for modern large-scale resources like ARCHS4 or recount3. Here, we introduce PLIERv2, which overcomes these constraints through a two-phase algorithmic design (an unsupervised "PLIERbase" initialization followed by a "PLIERfull" regression that incorporates priors via glmnet), rigorous internal cross-validation to tune regularization parameters for each latent variable, and efficient on-disk data handling using memory-mapped matrices from the bigstatsr package. Benchmarking on GTEx, recount2, and ARCHS4 demonstrates that PLIERv2 achieves 7×-41× speedups over PLIERv1, succeeds in modeling hundreds of thousands of samples that PLIERv1 cannot handle, and maintains or improves biological specificity of latent variables as shown by tissue-alignment and pathway enrichment analyses. By filling the gap in scalable, biologically informed latent variable extraction, PLIERv2 enables comprehensive analysis of modern transcriptomic compendia and paves the way for deeper insights into gene regulatory networks and downstream applications in translational genomics.

Identifiers

PMID40501901
PMCPMC12157376

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.